Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products
Integrated Ventures (OTCQB: INTV) has announced its strategic entry into the health and wellness sector, focusing on the GLP-1 market. The company has established a new subsidiary, MedWell USA, , which will serve as a B2B Procurement Agent for pharmaceutical products, particularly in the medical weight loss market.
MedWell USA will target B2B clients such as medical offices, fitness facilities, and wellness clinics. CEO Steve Rubakh highlighted the significant growth potential in this sector, citing a UBS Securities forecast that projects the combined GLP-1 market for obesity and diabetes to reach $129 billion by 2029, with 40 million users and a 30% CAGR.
Integrated Ventures plans to establish two more subsidiaries and is finalizing strategic joint ventures to penetrate the health and wellness market effectively.
Integrated Ventures (OTCQB: INTV) ha annunciato il suo ingresso strategico nel settore della salute e del benessere, focalizzandosi sul mercato dei GLP-1. L'azienda ha istituito una nuova sussidiaria, MedWell USA, che fungerà da Agente di Approvvigionamento B2B per prodotti farmaceutici, in particolare nel mercato della perdita di peso medico.
MedWell USA si concentrerà su clienti B2B come studi medici, palestre e cliniche di benessere. Il CEO Steve Rubakh ha sottolineato il significativo potenziale di crescita in questo settore, citando una previsione di UBS Securities che prevede che il mercato combinato dei GLP-1 per obesità e diabete raggiunga 129 miliardi di dollari entro il 2029, con 40 milioni di utenti e un CAGR del 30%.
Integrated Ventures ha in programma di stabilire altre due sussidiarie e sta finalizzando alleanze strategiche per penetrare efficacemente nel mercato della salute e del benessere.
Integrated Ventures (OTCQB: INTV) ha anunciado su entrada estratégica en el sector de la salud y el bienestar, centrándose en el mercado de GLP-1. La empresa ha establecido una nueva subsidiaria, MedWell USA, que servirá como un Agente de Adquisición B2B para productos farmacéuticos, particularmente en el mercado de pérdida de peso médico.
MedWell USA se dirigirá a clientes B2B como consultorios médicos, centros de fitness y clínicas de bienestar. El CEO Steve Rubakh destacó el significativo potencial de crecimiento en este sector, citando una proyección de UBS Securities que estima que el mercado combinado de GLP-1 para obesidad y diabetes alcanzará 129 mil millones de dólares para 2029, con 40 millones de usuarios y un CAGR del 30%.
Integrated Ventures planea establecer dos subsidiarias más y está finalizando asociaciones estratégicas para penetrar efectivamente en el mercado de la salud y el bienestar.
인티그레이티드 벤처스(OTCQB: INTV)가 건강 및 웰니스 분야에 전략적으로 진입했다고 발표하며, GLP-1 시장에 집중하고 있습니다. 이 회사는 MedWell USA라는 새로운 자회사를 설립했으며, 이는 제약 제품을 위한 B2B 구매 대행사로 활동하게 됩니다. 특히, 의료 체중 감량 시장에서 활동할 예정입니다.
MedWell USA는 의료 사무소, 피트니스 시설 및 웰니스 클리닉과 같은 B2B 고객을 목표로 삼습니다. CEO 스티브 루바크는 이 분야의 중요한 성장 잠재력을 강조하며, UBS 증권사의 예측을 인용하여 비만 및 당뇨병을 위한 GLP-1 시장이 2029년까지 1,290억 달러에 이를 것이며, 4천만 명의 사용자가 있을 것이고 30%의 CAGR이 있을 것이라고 말했습니다.
인티그레이티드 벤처스는 두 개의 추가 자회사를 설립할 계획이며 건강 및 웰니스 시장에 효과적으로 침투하기 위한 전략적 합작 ventures를 마무리하고 있습니다.
Integrated Ventures (OTCQB: INTV) a annoncé son entrée stratégique sur le marché de la santé et du bien-être, en se concentrant sur le marché des GLP-1. L'entreprise a créé une nouvelle filiale, MedWell USA, qui servira d'agent d'approvisionnement B2B pour les produits pharmaceutiques, en particulier dans le secteur de la perte de poids médical.
MedWell USA ciblera des clients B2B tels que des cabinets médicaux, des installations de fitness et des cliniques de bien-être. Le PDG Steve Rubakh a souligné le potentiel de croissance significatif dans ce secteur, citant une prévision de UBS Securities qui prévoit que le marché combiné des GLP-1 pour l'obésité et le diabète atteindra 129 milliards de dollars d'ici 2029, avec 40 millions d'utilisateurs et un CAGR de 30%.
Integrated Ventures prévoit d'établir deux autres filiales et finalise des partenariats stratégiques pour pénétrer efficacement le marché de la santé et du bien-être.
Integrated Ventures (OTCQB: INTV) hat seinen strategischen Einstieg in den Gesundheits- und Wellnesssektor angekündigt und fokussiert sich auf den GLP-1 Markt. Das Unternehmen hat eine neue Tochtergesellschaft, MedWell USA, gegründet, die als B2B Beschaffungsagent für pharmazeutische Produkte fungieren wird, insbesondere im Bereich der medizinischen Gewichtsreduktion.
MedWell USA wird B2B-Kunden wie Arztpraxen, Fitnessstudios und Wellness-Kliniken anvisieren. CEO Steve Rubakh hoben das signifikante Wachstumspotenzial in diesem Sektor hervor und verwies auf eine Prognose von UBS Securities, die voraussagt, dass der kombinierte GLP-1 Markt für Fettleibigkeit und Diabetes bis 2029 eine Größe von 129 Milliarden Dollar erreichen wird, mit 40 Millionen Nutzern und einem CAGR von 30%.
Integrated Ventures plant, zwei weitere Tochtergesellschaften zu gründen und finalisiert strategische Joint Ventures, um effektiv in den Gesundheits- und Wellnessmarkt einzutreten.
- Entry into the rapidly expanding health and wellness sector
- Focus on the booming GLP-1 market, projected to reach $129 billion by 2029
- Establishment of MedWell USA as a B2B Procurement Agent
- Plans for two additional subsidiaries to broaden weight loss operations
- Finalizing strategic joint ventures for market penetration
- None.
The initial phase of this transition will be led by the newly established subsidiary, MedWell
MedWell
Steve Rubakh, CEO of Integrated Ventures, comments: "This strategic entry represents a significant evolution for our company. The health and wellness sector offers immense growth potential, and we are eager to bring unique and impactful solutions (B2B and B2C) to market that will meet the critical needs of consumers seeking to improve their health and well-being. According to UB Securities (*) forecast, the combined GLP-1 market for obesity and diabetes will reach
In addition to launching MedWell
Integrated Ventures is committed to driving shareholder value by seizing high-growth opportunities within the health and wellness sector. The Company will provide regular updates as it advances its strategic plans and achieves key milestones.
(*) https://www.ubs.com/global/en/investment-bank/in-focus/2024/glp-1-a-medication.html
About Integrated Ventures, Inc:
Integrated Ventures, Inc. is a diversified holdings company that develops, acquires, operates, and invests in unique businesses. The Company's current operations include digital currency mining and hosting.
About MedWell
MedWell
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
Contact:
(215) 613-9898 sr@integratedventures.io
View original content:https://www.prnewswire.com/news-releases/integrated-ventures-announces-strategic-entry-into-health--wellness-industry-with-focus-on-glp-1-products-302232911.html
SOURCE Integrated Ventures Inc.
FAQ
What is Integrated Ventures' (INTV) new business focus?
What is the projected market size for GLP-1 products by 2029?
Who are the target clients for MedWell USA, INTV's new subsidiary?
What are Integrated Ventures' (INTV) plans for expansion in the health and wellness sector?
